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Abstract
Objective—We sought to determine the association between time to initial antibiotics and
mortality of septic shock patients treated with an emergency department (ED) based early
resuscitation protocol.
Design—Pre-planned analysis of a multicenter randomized controlled trial of early sepsis
resuscitation.
Setting—3 urban US EDs.
Patients—Adult septic shock patients.
Interventions—A quantitative resuscitation protocol in the ED targeting 3 physiological
variables: central venous pressure, mean arterial pressure and either central venous oxygen
saturation or lactate clearance. The study protocol was continued until all endpoints were achieved
or a maximum of 6 hours.
Measurements—Data on patients who received an initial dose of antibiotics after presentation
to the ED were categorized based on both time from triage and time from shock recognition to
initiation of antibiotics. The primary outcome was in-hospital mortality.
Main Results—Of 291 included patients, mortality did not change with hourly delays in
antibiotic administration up to 6 hours after triage: 1 hour (OR 1.2, 0.6–2.5), 2 hours (OR 0.71,
0.4–1.3), 3 hours (OR 0.59, 0.3–1.3). Mortality was significantly increased patients who received
initial antibiotics after shock recognition (N=172, 59%) compared with before shock recognition
(OR 2.4, 1.1–4.5); however, among patients who received antibiotics after shock recognition,
mortality did not change with hourly delays in antibiotic administration.
Conclusion—In this large, prospective study of ED patients with septic shock, we found no
increase in mortality with each hour delay to administration of antibiotics after triage. However,
delay in antibiotics until after shock recognition was associated with increased mortality.
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Introduction
Severe sepsis hospitalizations have doubled over the last decade resulting in at least 750,000
persons affected annually in the United States (US).(1;2) Estimates suggest that 500,000
patients with severe sepsis are treated annually in US emergency departments (ED).(3) The
Surviving Sepsis Campaign (SSC) international consensus guidelines recommend initiating
broad-spectrum antibiotic coverage within the first hour of recognizing severe sepsis and
septic shock.(4) These recommendations are based largely upon one large retrospective
study(5) and expert consensus. Despite these guidelines, a recent large cohort of 165
hospitals treating over 15,000 patients with septic shock from the SSC registry demonstrated
that only 68% of patients received broad-spectrum antibiotics within 3 hours of ED
presentation,(6) demonstrating the difficulty of achieving antibiotic administration within
current guidelines in routine clinical practice.
To date no prospective study has examined the timing of antibiotic administration and its
association with mortality in ED sepsis patients treated with an early quantitative
resuscitation protocol. Thus, the optimal timing of antibiotic administration and its impact
on outcome remains unclear in the early treatment of severe sepsis and septic shock. The
aim of this study was to evaluate if the timing of antibiotic administration in relation to both
triage time and time of shock recognition was associated with in-hospital mortality among a
group of consecutive, prospectively enrolled patients presenting to three US EDs with septic
shock and treated with an early quantitative resuscitation protocol.
Methods
Study Design
We conducted a preplanned analysis of a recently completed prospective, parallel group,
non-blinded randomized clinical trial designed to assess the non-inferiority of lactate
clearance versus central venous oxygen saturation (ScvO2) as the protocol endpoint that
evaluated the adequacy of oxygen delivery during ED based early quantitative resuscitation
of sepsis.(7)
The trial took place from January 2007 to January 2009 at Carolinas Medical Center,
Charlotte, NC, Beth Israel Deaconess Medical Center, Boston, MA, and Cooper University
Hospital, Camden, NJ, all of which are large, urban, tertiary care hospitals staffed by
emergency medicine resident physicians supervised by board certified emergency medicine
attending physicians. The study was approved by the Institutional Review Board at each
institution and all participants or their surrogate provided written informed consent for
participation. The trial was registered on Clinicatrials.gov identifier NCT00372502.
The detailed methods of the study have been described.(7) In brief, consecutive patients
presenting to one of the participating EDs were eligible for enrollment if they were older
than 17 years, had confirmed or suspected infection, two or more systemic inflammatory
response criteria(8), and hypoperfusion evidenced by hypotension after fluid challenge or a
blood lactate concentration of at least 4 mmol/L. After enrollment patients were randomly
assigned to 1 of 2 groups. Each group received structured quantitative resuscitation while in
the ED. The study protocol was continued until all endpoints were achieved or a maximum
of 6 hours. The published results of this study showed a 6% (95% confidence intervals −3 to
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14%) in-hospital mortality difference between the two study groups, confirming the primary
hypothesis of non-inferiority between the two resuscitation endpoints.(7)
As a part of the protocol, all patients received broad spectrum antibiotic coverage according
to local hospital guidelines. The Online Supplement provides an example of one of the
antibiotic guidelines. The only requirement for antibiotic administration was that they be
administered as early as possible after recognition of sepsis.
Data Analysis and Outcomes
The primary outcome was in-hospital mortality. We compared the outcomes of subjects who
received an initial dose of antibiotics after compared to before each hourly increment up to a
maximum of 6 hours after ED triage. We also compared outcomes of patients receiving
initial antibiotics after compared to before each hourly increment after shock recognition.
Shock recognition was defined as the time that the patient developed 2 or more SIRS criteria
and either a systolic blood pressure (SBP) lower than 90 mmHg after a minimum of 20 mL/
kg rapid volume challenge or a blood lactate concentration of at least 4 mmol/L.
Recognizing that some patients would receive antibiotics before shock recognition, we
analyzed outcomes of patients that received antibiotics prior compared to after recognition
of shock; however, if patients received antibiotics prior to shock recognition they were
excluded from the hourly incremental analysis.
One infectious disease specialist reviewed the blood culture and clinical data from all
subjects. We followed our previously published criteria for determining positive blood
cultures.(9) A positive blood culture required that a bacterial or fungal pathogen be isolated
by routine culture in the blood. Staphylococcus epidermidis was uniformly considered a
contaminate and other coagulase negative staphylococci were similarly considered to be
unlikely to cause septic shock and were considered contaminates unless the patient had a
preexisting indwelling venous catheter. Antibiotic administration was considered
appropriate if the patient received an initial antimicrobial to which the cultured bacteria had
in vitro sensitivity. In the case of negative cultures, antibiotics were considered appropriate
if they were given in accordance with local guidelines and were extended spectrum
antibiotics.
Categorical data are presented as proportions with 95% confidence intervals (CI).
Continuous data are presented as means and standard deviations or medians and interquartile
ranges. Results were compared using chi-squared, Fisher exact, Mann-Whitney, or Krussel-
Wallis tests as appropriate. In order to attempt to control for potential confounders, we
constructed a multivariate logistic regression model using inhospital death as the dependent
variable. Candidate variables were compared using the Krussel-Wallis test to assess for
differences in hourly intervals versus the entire cohort, and were added to the multivariate
model if p<0.10 in order to maintain the event (death) per independent variable ratio of
approximately 8–10:1 that is necessary for multivariate modeling.(10) The model was
refined using reverse stepwise elimination. Model fit was determined with Hosmer and
Lemeshow’s goodness of fit test. All statistical tests were two sided with p<0.05 considered
significant. Data were analyzed using commercially available statistical software
(StatsDirect 2.7.7, Cheshire, England and STATA 10.0, College Station, TX).
Results
Of 300 patients enrolled in study 291 received a first dose of antibiotics after presentation to
the hospital. The remaining 9 patients had received antibiotics prior to hospital arrival (7
from another outpatient facility, 2 from rehabilitation/chronic nursing facility) and were
excluded from subsequent analysis. Fifty nine percent (172/291) of patients received the
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initial dose of antibiotics after recognition of shock. Baseline characteristics of the entire
cohort are shown in Table 1 and the various sources of infection are shown in Table 2.
Overall mortality was 55/291 (18.9%).
Positive blood cultures for pathological organisms were obtained in 100 of 291 (34.4%)
patients. The organisms isolated from the blood and their frequencies of occurrence are
summarized in Table 3. The mortality rate for blood culture positive septic shock was
26/100 (26.0%) versus 29/191 (15.2%), for blood culture negative septic shock; p=0.03. Of
the 100 patients with positive blood cultures, 91 received antibiotics in the ED to which the
causative organism was susceptible. Of the 9 patients who failed to receive appropriate
antibiotics, 7/9 received broad spectrum antibiotics to which the causative organism was
resistant (multidrug resistant gram-negative rods in 6/9, and multidrug resistant enterococci
in1/9), and 2/9 patients had fungemia that was untreated in the ED. The mortality for
patients treated with appropriate antibiotics for blood culture positive sepsis in the
emergency department was 23/91 (25.3%) vs 3/9 (33.3%), for those treated with
inappropriate antibiotics; p = 0.69.
The median time from triage to initial antibiotic administration was 115 minutes (IQR 65,
175). Table 4 summarizes the relative mortality and odds ratios for death associated with
hourly intervals from ED triage to antibiotic administration among all 291 subjects. Figure 1
depicts the time from triage to initial antibiotics in the entire cohort, stratified by final
hospital outcome (alive versus dead). We found no association between in-hospital mortality
and the time from ED triage to administration of antibiotics during the first 6 hours of
resuscitation.
The median time to shock recognition among all subjects was 89 minutes (IQR 48, 180). A
total of 172 (59%) patients received antibiotics after shock recognition. When compared
with patients who received antibiotics before shock recognition (n=119), patients receiving
antibiotics after shock recognition had a significant increase in the odds of death (OR 2.4,
95% CI 1.1 to 4.5). Figure 2 depicts the time from shock recognition to initial antibiotics in
the entire cohort, stratified by final hospital outcome (alive versus dead).
Table 5 summarizes the relative mortality and odds ratios for death associated with hourly
intervals from shock recognition to antibiotic administration among the 172 subjects who
received antibiotics after shock recognition. We found no increase in mortality associated
with delay to administration of antibiotics during the first 3 hours after shock recognition.
Only 8 patients received antibiotics after 3 hours of shock recognition
In order to attempt to control for potential confounders, we constructed a multivariate
logistic regression model using in-hospital death as the dependent variable. The final model
included age, total SOFA score at enrollment, initial lactate, race, and achievement of lactate
clearance goal. As the independent variables of most interest, time to antibiotics at each time
point cutoff and appropriate antibiotics were forced into the final models. The final model
demonstrated goodness-of-fit by Hosmer and Lemeshow’s (p=0.27). The adjusted odds
ratios revealed no significant changes from the unadjusted odds ratios and are shown in
Tables 4 and 5.
Discussion
In this report, we document the association between timing of initial antibiotic treatment and
mortality in emergency department patients undergoing a quantitative resuscitation protocol
for septic shock. Our results indicate no association between time from triage to initial
antibiotic administration and hospital mortality. However, our data suggest an increased risk
of death if antibiotics are delayed until after the recognition of shock. Once a patient meets
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consensus definition for shock, our data showed no association between subsequent hourly
delays in antibiotic administration and mortality.
The Surviving Sepsis Campaign (SSC) international consensus guidelines recommends
always administering broad spectrum antibiotics within the first hour of recognizing severe
sepsis and septic shock.(4) This recommendation is largely based on one large retrospective
study published in 2006.(5) In that study Kumar et al reported that administration of
antimicrobials within the first hour of documented hypotension was associated with a
survival rate of 79.9%. Each hour of delay in antimicrobial administration over the ensuing
6 hrs was associated with an average decrease in survival of 7.6%. These findings were not
confirmed by our data presented in this report. There are several considerations that may
explain these differences in findings. First, the Kumar et al study included all intensive care
unit (ICU) patients diagnosed with septic shock, and the overall reported mortality rate was
56%. Thus it appears that this cohort of subjects had a higher severity of illness than the
present study. Furthermore, we studied cohort of only ED patients, rather than patients
presenting from a variety of settings and likely receiving various methods of initial
resuscitation. Our overall mortality rate was 19%, consistent with other studies of ED
patients receiving early aggressive resuscitation.(11–13) While Kumar et al attempted to
control for the variability of resuscitation, it is likely that the initial resuscitative efforts
across such a wide spectrum of patients in various care settings were considerably different.
As such, the extrapolation of this retrospective data from an ICU patient population to the
earliest hours of resuscitation in ED patients receiving standardized resuscitation may be
inappropriate. All of the patients in the current study underwent the same early recognition
and aggressive treatment protocol, likely resulting in more uniform screening and initial
resuscitative efforts, and may provide additional explanation for the differences in findings.
That is, when sepsis recognition and resuscitation are early, aggressive and prescribed, the
administration of antibiotic measured in hourly increments of time is less important than is
just administering the antibiotics during the initial resuscitative phase.
Our data are consistent with the findings of Gaieski et al, who published a retrospective
analysis evaluating the timing of antibiotics and association with mortality in ED patients
treated with an early goal-directed therapy (EGDT) protocol.(14) However, similar to
Kumar et al, the Gaieski report emphasizes appropriateness of antibiotic administration in
their conclusions. In our report, we made an a priori decision to evaluate only initial
antibiotic administration, and not put major emphasis on if the antibiotic coverage was
considered appropriate, as has been proposed by both Kumar and Gaieski.(5;14) We had two
important rationales for our decision. First, while it makes intuitive sense to only measure
the effect of an antibiotic with activity against the causative organism, the reality of
accurately performing this measurement in a clinical setting, particularly the ED, is nearly
impossible. Appropriateness of antibiotics is based on culture data not available for 24 to 96
hours or longer after initial antibiotic administration and therefore it is impossible for a
clinician to know if a prescribed antibiotic is appropriate. Thus it seems inappropriate to
require this standard when determining the effect of antibiotic timing on outcome. Our
rationale is similar to that for determination of appropriateness of cardiac catheterization
laboratory activation for ST segment myocardial infarction being based on the initial
evaluation and EKG, not the presence or absence of a culprit lesion.(15) Second, despite the
best attempt of authors to standardize the evaluation of appropriateness of antibiotics, the
measure is performed retrospectively and is extremely complex and subject to interpretation.
Interestingly this issue is not just semantics, particularly given the high rate of culture-
negative septic shock, 30–43% in the aforementioned studies, leading to a dual standard of
appropriateness based upon the presence or absence of a positive culture. Appropriateness in
these cases of culture negative sepsis is relegated to ‘broad spectrum’, which can be argued
to be less restrictive than the evaluation of culture positive subjects. Furthermore, all studies
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of septic shock require a subjective analysis of the causative organism. Such a judgment is
particularly difficult in cases where more than one culture is positive with different
organisms, and subjective decisions as to the causative organism must be made, even if they
are made with predefined decision rules. Factors such as presence of a indwelling urinary or
venous catheter, presence of an immunocompromised state that allows “contaminants” to
become virulent sources of infection, and nosomcosial exposures all confound these
analyses and are extraordinarily difficult to standardize and control.
With the aforementioned rational taken into consideration, appropriateness of antibiotics
could have been an important confounder of our findings. Thus we incorporated
appropriateness of antibiotics in our multivariate model. These adjusted results were nearly
identical as our unadjusted results. Namely, there appears to be no association between
hourly delays in antibiotic administration after triage and mortality, even when controlling
for appropriateness. We interpret these results to suggest that when all other parts of early
resuscitation are sufficiently refined, the importance of timeliness of antibiotics appears to
recede.
The strength of this study is that we prospectively studied the timing of antibiotic
administration to ED patients with septic shock. All patients received a standardized,
prescribed early recognition and resuscitation protocol, removing much of the variability in
both patient population and early treatment present in other studies. In general, patients
received antibiotics early in their hospital course, with 75% of patients receiving initial
antibiotics within 3 hours and 97% within 6 hours of triage.
This study has several weaknesses which deserve consideration. First, all three of the
hospital systems have considerable experience with early quantitative resuscitation
protocols, and our results may not be generalizable to hospitals without such protocols.
Second, the vast majority of patients received antibiotics within 3 hours of triage, and the
relatively small numbers of patients in subsequent time points leads to wide confidence
intervals, and makes it more difficult to draw definitive conclusions regarding associations
as time points become progressively longer. Third, while we did not observe significant
associations in our study it is possible that a larger study would be able to detect a
difference. Given our confidence intervals, however, we would expect such an effect size to
be small, and significantly less than those previously reported.(5;14) Fourth, while our
mortality rate is similar to previous reports(11–13), it is lower than reports in other septic
shock populations.(16;17) Fifth, it is impossible in most cases to identify the exact time of
onset of septic shock and thus the timing of antibiotics in relation to onset of shock can often
not be ascertained. This is an inherent limitation to the nature of sepsis research. Finally,
given the design of our study, we are only able to draw conclusions regarding associations
and not causation.
Conclusion
In this large prospective study of ED septic shock patients who received standardized early
recognition and aggressive resuscitation at 3 experienced institutions, we failed to
demonstrate an association between timing of antibiotic administration from ED triage and
hospital mortality. A delay in antibiotics until after shock recognition, as compared to
before, was associated with increased mortality; however if antibiotics are administered after
shock recognition there is no increase in mortality with hourly delays.
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Figure 1.
Graphical depiction of the time from triage to initial antibiotics in the entire cohort, stratified
by final hospital outcome. Grey bars represent patients who survived the hospitalization and
black bars represent patients who died in the hospital.
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Figure 2.
Graphical depiction of the time from shock recognition to initial antibiotics in the entire
cohort, stratified by final hospital outcome. Shock recognition is indicated by Time 0.
Subjects with negative times received antibiotics before shock recognition. Grey bars
represent patients who survived the hospitalization and black bars represent patients who
died in the hospital.
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Table 1
Patient demographics and clinical characteristics.
Variable (n=291) Value
Age (IQR) 62 (50, 73)
Race (%)
 Caucasian 158 (54)
 Black American 101 (34)
 Hispanic 27 (9)
 Other 5 (2)
Sex (%)
 Male 156 (53)
 Female 135 (46)
Eligibility Criteria (IQR)
 Temperature (°F) 99 (97, 101)
 Heart rate (beats per minute) 102 (85, 112)
 Respiratory rate (breaths per minute) 22 (18, 27)
 White blood count (cells per mm3) 12.4 (7.7, 17.5)
 Systolic Blood Pressure (mmHg) 86 (77, 98)
 Lactate (mmol/L) 3.3 (1.8, 5.8)
Baseline Laboratory Values (IQR)
 Platelets (per mm3) 214 (135, 294)
 Hemoglobin (mg/dL) 11.4 (9.8, 13.4)
 Creatinine (mg/dl) 1.7 (1.1, 3.0)
 Total Bilirubin (mg/dL) 1.0 (0.6, 1.6)
 HCO3 (mg/dL) 21 (17, 24)
 International normalized ratio 1.3 (1.1, 1.7)
Disease severity (IQR) *
 SAPS II score 42 (30, 55)
 SOFA score 6 (4,9)
 MEDS score 11 (8, 14)
Abbreviations: IQR – interquartile range; SAPS - simple acute physiology score; SOFA - Sequential Organ Failure Assessment; MEDS - mortality
in emergency department sepsis; F – Fahrenheit; mm – millimeter; Hg – mercury; mg – milligram; dL - deciliter
*
At 0 hours
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Table 2
Source of infection.
Source N (%)
Pneumonia 99 (34.0)
Urinary tract infection 71 (24.4)
Intraabdominal 49 (16.8)
Skin and soft tissue 23 (7.9)
Indwelling intravascular catheter 11 (3.8)
Surgical Wound 7 (2.4)
Endocarditis 4 (1.4)
Meningitis 3 (1.0)
Septic arthritis 2 (0.7)
Tuberculosis 1 (0.3)
Ear, nose, thorat 1 (0.3)
Toxic shock syndrome 1 (0.3)
Unknown 40 (13.8)
Two or more sources 21 (7.2)
N – number of patients
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Table 3
Organisms isolated from the blood.
N
Gram positive organisms
 Staphylococcus aureus 21
  Methicillin sensitive 11
  Methicillin resistant 10
 Coagulase negative staphylococcus 1
 Streptococcus pneumoniae 7
 Other streptococcus species 9
 Enterococcus species 8
 Peptostreptococcus 1
 Bacillus cereus 1
 Clostridium perfringens 2
 Diptherioids 2
 Micrococcus 1
 Lactobacillus 1
Gram negative organisms
 Escherichia coli 17
 Klebsiella species. 7
 Proteus species 7
 Serretia marcescens 4
 Pseudomonas species 2
 Enterobacter species 2
 Vibrio vulnificus 1
 Acinetobacter species 1
 Morgonella species 1
 Citrobacter species 1
Yeast/Fungi
 Candida species 3
Positive Blood Cultures 100
N – number of patients
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